Why the study?
Diabetes mellitus accelerates coronary artery disease progression, increasing cardiovascular complications and mortality.
Does diabetes mellitus accelerate the progression of coronary artery disease?
Does diabetes mellitus accelerate the progression of coronary artery disease?
Diabetes mellitus is an independent predictor of coronary artery disease progression, highlighting the need for aggressive risk factor management in this population.
DM may accelerate CAD progression; hypothesis-generating and should not yet change practice.
Background: Diabetes mellitus (DM) accelerates the progression of coronary artery disease (CAD), increasing the risk of cardiovascular complications and mortality. Aims and Objectives: The aims of this study were to evaluate the impact of DM on the progression of CAD over a 2-year period and identify key risk factors and biomarkers associated with adverse cardiovascular outcomes in diabetic patients. Materials and Methods: This observational study included 100 participants, divided into two groups: 50 patients with DM and 50 non-diabetic controls. Demographic and clinical characteristics, including age, gender, body mass index (BMI), and baseline CAD characteristics, were recorded. Participants were followed for 2 years to assess the progression of CAD and new cardiovascular events. Risk factors such as hemoglobin A1c (HbA1c) levels, low-density lipoprotein (LDL) cholesterol, and C-reactive protein (CRP) were also measured. Statistical analyses, including multivariate logistic regression, were performed to identify independent predictors of CAD progression. Results: The diabetic group had a significantly higher BMI (29.1±4.6 kg/m1 vs. 26.5±3.9 kg/m1r P=0.01) and prevalence of CAD (80% vs. 60%, P=0.03). CAD progression was observed in 56% of diabetic patients compared to 30% of controls (P=0.01). New cardiovascular events occurred in 24% of diabetics versus 12% of controls (P=0.08). Diabetic patients had higher HbA1c (8.2%±1.1 vs. 5.6%±0.7, P<0.001), LDL cholesterol (130.4±25.6 mg/dL vs.115.8±22.3 mg/dL, P=0.04), and CRP levels (3.2±1.4 mg/L vs. 1.8±1.0 mg/L, P=0.001). DM was an independent predictor of CAD progression (OR=2.9, 95% CI=1.4–5.8,P=0.003). Conclusion: DM significantly impacts CAD progression, emphasizing the need for aggressive risk factor management in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Ramesh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: